Preparation of Drug Liposomes by Reverse-Phase Evaporation

  • Nian-Qiu ShiEmail author
  • Xian-Rong Qi
Living reference work entry
Part of the Biomaterial Engineering book series (BIOENG)


Liposomes display increased therapies for a series of biomedical application by stabilizing loaded payloads, overcoming shortcomings to cellular and tissue uptake, and enhancing biodistribution of payloads to target sites in vivo. The Bangham method or thin lipid film hydration technology was the first described method for constructing liposomes. The drawbacks of this method involve sonicator contact with the liposomes, and risk of high-temperature exposure may lead to phospholipid/drug damage and deceased encapsulation. A generally adopted preparative alternative is the reverse-phase evaporation technique that tends to form inverted micelles or water-in-oil emulsions. The water phase carries the drug, and organic phase is made up of the lipids for forming the liposome bilayer. The lipid mixture is dissolved in solvents, and the lipid solvents are evaporated. Formed lipid film after evaporation is redissolved in an organic phase. Under reduced pressure condition, the organic solvent can be slowly evaporated, initially resulting in the conversion of the dispersion into a viscous gel and finally generating an aqueous suspension containing the liposomes. Similar to other preparation methods, the size of liposome generated by reverse-phase evaporation technique needs to be reduced by multiple extrusions through a polycarbonate membrane. The number of extrusion cycles and the size of polycarbonate membrane pore influence the degree of size reduction and the final particle size and distribution. This paper summarized the preparation procedure and formation principle of various payload-loaded liposomes by reverse-phase evaporation technique.


Liposomes Reverse- phase evaporation Encapsulation efficiency Sizes Electron micrograph 


  1. Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13(1):238–252CrossRefGoogle Scholar
  2. Bozzuto G, Molinari A (2015) Liposomes as nanomedical devices. Int J Nanomed 10:975–999CrossRefGoogle Scholar
  3. Cortesi R, Esposito E, Gambarin S, Telloli P, Menegatti E, Nastruzzi C (1999) Preparation of liposomes by reverse-phase evaporation using alternative organic solvents. J Microencapsul 16(2):251–256CrossRefGoogle Scholar
  4. Elorza B, Elorza MA, Frutos G, Chantres JR (1993) Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: study of drug release. Biochim Biophys Acta 1153(2):135–142CrossRefGoogle Scholar
  5. Israelachvili JN, Marcelja S, Horn RG (1980) Physical principles of membrane organization. Q Rev Biophys 13(2):121–200CrossRefGoogle Scholar
  6. Koning GA, Storm G (2003) Targeted drug delivery systems for the intracellular delivery of macromolecular drugs. Drug Discov Today 8(11):482–483CrossRefGoogle Scholar
  7. Lasic DD (1998) Novel applications of liposomes. Trends Biotechnol 16(7):307–321CrossRefGoogle Scholar
  8. Madni A, Sarfraz M, Rehman M, Ahmad M, Akhtar N, Ahmad S, Tahir N, Ijaz S, Al-Kassas R, Löbenberg R (2014) Liposomal drug delivery: a versatile platform for challenging clinical applications. J Pharm Pharm Sci 17(3):401–426CrossRefGoogle Scholar
  9. Metselaar JM, Storm G (2005) Liposomes in the treatment of inflammatory disorders. Expert Opin Drug Deliv 2(3):465–476CrossRefGoogle Scholar
  10. Mozafari MR (2005) Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett 10(4):711–719Google Scholar
  11. Mozafari MR, Johnson C, Hatziantoniou S, Demetzos C (2008) Nanoliposomes and their applications in food nanotechnology. J Liposome Res 18(4):309–327CrossRefGoogle Scholar
  12. Mu L, Sprando RL (2010) Application of nanotechnology in cosmetics. Pharm Res 27(8):1746–1749CrossRefGoogle Scholar
  13. Pattni BS, Chupin VV, Torchilin VP (2015) New developments in liposomal drug delivery. Chem Rev 115(19):10938–10966CrossRefGoogle Scholar
  14. Qi XR, Maitani Y, Nagai T (1995a) Effect of soybean-derived sterols on the in vitro stability and the blood circulation of liposomes in mice. Int J Pharm 114(1):33–41CrossRefGoogle Scholar
  15. Qi XR, Maitani Y, Nagai T (1995b) Rates of systemic degradation and reticuloendothelial system uptake of calcein in the dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols in mice. Pharm Res 12(1):49–52CrossRefGoogle Scholar
  16. Qi XR, Maitani Y, Shimoda N, Sakaguchi K, Nagai T (1995c) Evaluation of liposomal erythropoietin prepared with reverse-phase evaporation vesicle method by subcutaneous administration in rats. Chem Pharm Bull 43:295–299CrossRefGoogle Scholar
  17. Qi XR, Maitani Y, Nagai T, Wei SL (1997) Comparative pharmacokinetics and antitumor efficacy of doxorubicin encapsulated in soybean-derived sterols and poly(ethylene glycol) liposomes in mice. Int J Pharm 146(1):31–39CrossRefGoogle Scholar
  18. Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286CrossRefGoogle Scholar
  19. Szoka F Jr, Papahadjopoulos D (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 75(9):4194–4198CrossRefGoogle Scholar
  20. Xiang B, Dong DW, Shi NQ, Gao W, Yang ZZ, Cui Y, Cao DY, Qi XR (2013) PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials 34(28):6976–6991CrossRefGoogle Scholar
  21. Yang ZZ, Li JQ, Wang ZZ, Dong DW, Qi XR (2014) Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Biomaterials 35(19):5226–5239CrossRefGoogle Scholar
  22. Zhao W, Zhuang S, Qi XR (2011) Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes. Int J Nanomed 6:3087–3098Google Scholar

Copyright information

© Springer-Verlag GmbH Germany 2018

Authors and Affiliations

  1. 1.Department of Pharmaceutics, School of PharmacyJilin Medical UniversityJilinChina
  2. 2.Department of Pharmaceutics, School of Pharmaceutical SciencePeking UniversityBeijingChina

Personalised recommendations